Rhinitis medicamentosa. 1981

W B Chodirker

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012220 Rhinitis Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES. Nasal Catarrh,Catarrh, Nasal,Catarrhs, Nasal,Nasal Catarrhs,Rhinitides
D014663 Nasal Decongestants Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) Decongestant,Decongestants,Nasal Decongestant,Vasoconstrictor Agents, Nasal,Vasoconstrictors, Nasal,Agents, Nasal Vasoconstrictor,Decongestant, Nasal,Decongestants, Nasal,Nasal Vasoconstrictor Agents,Nasal Vasoconstrictors

Related Publications

W B Chodirker
September 1946, Proceedings of the staff meetings. Mayo Clinic,
W B Chodirker
August 1968, Annals of allergy,
W B Chodirker
April 1980, Canadian Medical Association journal,
W B Chodirker
October 1981, The Laryngoscope,
W B Chodirker
January 2020, Vestnik otorinolaringologii,
W B Chodirker
May 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
W B Chodirker
June 1987, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
W B Chodirker
January 2006, Journal of investigational allergology & clinical immunology,
W B Chodirker
November 2021, BMJ case reports,
W B Chodirker
January 2007, Clinical allergy and immunology,
Copied contents to your clipboard!